These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15694668)

  • 1. Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma.
    Takano T; Miyauchi A; Yoshida H; Kuma K; Amino N
    Cancer Lett; 2005 Feb; 219(1):91-6. PubMed ID: 15694668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aspiration biopsy-nucleic acid diagnosis for widely used preparative testing].
    Takano T
    Rinsho Byori; 2012 Feb; 60(2):132-8. PubMed ID: 22568094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas.
    Takano T; Miyauchi A; Yoshida H; Kuma K; Amino N
    Br J Cancer; 2004 Apr; 90(8):1600-5. PubMed ID: 15083192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction.
    Bernet VJ; Anderson J; Vaishnav Y; Solomon B; Adair CF; Saji M; Burman KD; Burch HB; Ringel MD
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4792-6. PubMed ID: 12364475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trefoil factor 3 (TFF3): a promising indicator for diagnosing thyroid follicular carcinoma.
    Takano T; Yamada H
    Endocr J; 2009; 56(1):9-16. PubMed ID: 18506086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular-based diagnosis of thyroid carcinoma: germ-cell carcinogenesis and aspiration biopsy nucleic acid diagnosis(ABND)].
    Takano T; Amino N
    Rinsho Byori; 2004 Jan; 52(1):62-6. PubMed ID: 14968562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma.
    Jakubiak-Wielganowicz M; Kubiak R; Sygut J; Pomorski L; Kordek R
    Pol J Pathol; 2003; 54(2):111-5. PubMed ID: 14575419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of thyroid tumor cells in aspiration biopsies for aspiration biopsy nucleic acid diagnosis.
    Takano T; Higashiyama T; Uruno T; Yamada H; Yoshida H; Miyauchi A
    Head Neck; 2008 Aug; 30(8):983-90. PubMed ID: 18302262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
    Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
    Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
    Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors.
    Martins L; Matsuo SE; Ebina KN; Kulcsar MA; Friguglietti CU; Kimura ET
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4806-10. PubMed ID: 12364477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fifteen percent issue in molecular-based diagnosis of follicular thyroid carcinoma.
    Takano T
    Pathol Int; 2011 Mar; 61(3):165-6. PubMed ID: 21355960
    [No Abstract]   [Full Text] [Related]  

  • 14. Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.
    Patel MR; Bryson PC; Shores CG; Hart CF; Thorne LB; Deal AM; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):590-6. PubMed ID: 19528408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].
    Tang QS; Teng XD; Ding W; Zhou J; Yao HT; Ying LX; Xu LM
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):745-8. PubMed ID: 22336157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of Galectin-3 expression in the immunocytochemical evaluation of thyroid fine needle aspiration cytology.
    Ersoz S; Sert H; Yandi M; Erem C; Mungan S; Ersoz HO; Cobanoglu U; Hacihasanoglu A
    Pathol Oncol Res; 2008 Dec; 14(4):457-60. PubMed ID: 18415710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of TFF3 mRNA in aspirates from thyroid nodules using mesh filtration: the first clinical trial in 130 cases.
    Yamada H; Takano T; Kihara M; Hirokawa M; Yoshida H; Watanabe M; Iwatani Y; Hidaka Y; Miyauchi A
    Endocr J; 2012; 59(7):621-30. PubMed ID: 22572548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours.
    Karger S; Krause K; Gutknecht M; Schierle K; Graf D; Steinert F; Dralle H; Führer D
    Br J Cancer; 2012 Jan; 106(3):562-8. PubMed ID: 22223087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of blood and nucleic acid testing in diagnosis of thyroid carcinoma].
    Takano T
    Nihon Rinsho; 2007 Nov; 65(11):1991-5. PubMed ID: 18018560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
    Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
    Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.